On the hop here … but looks pretty good to me.
The key to success was dealing with a possible placebo effect which the design took care of with a long monitoring period before participants entered the trial. Plus keeping the attrition rate very low – which they did – with only one subject lost.
The effect size (about 5-6 points) is exactly what you would hope for – not just for statistical significance but also for clinical significance.
Of-course you would want to see supporting evidence coming out from the secondaries … but so far so good.
The good design here has translated good outcomes … as I had earlier argued (hoped) it might.
So well done ZLD … will read the journal paper with interest which will provide more details to look under the hood … but overall can’t fault anything from this announcement.
On the hop here … but looks pretty good to me. The key to...
-
- There are more pages in this discussion • 251 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.100(27.8%) |
Mkt cap ! $5.219M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 47.0¢ | 38.0¢ | $5.725K | 13.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1589 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 240 | 1 |
View Market Depth
| Last trade - 15.31pm 05/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |